Another subgroup analysis conducted based on cancer types showed that PTPRD/PTPRT mutant patients treated with ICIs had significantly longer OS than WT patients in NSCLC and SKCM, which is consistent with the results of previous studies (17, 33). Here, PTPRD is linked to cancer.